Cargando…
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan
The pandemic of COVID-19 is still ongoing, and many studies on serum antibodies have been reported, however, there are few studies about asymptomatic and mild patients. In this study, we enrolled 44 COVID-19 patients with relatively mild disease and 48 pre-pandemic controls. We measured serum antibo...
Autores principales: | Takeshita, Masaru, Nishina, Naoshi, Moriyama, Saya, Takahashi, Yoshimasa, Uwamino, Yoshifumi, Nagata, Mika, Aoki, Wataru, Masaki, Katsunori, Ishii, Makoto, Saya, Hideyuki, Kondo, Yasushi, Kaneko, Yuko, Suzuki, Katsuya, Fukunaga, Koichi, Takeuchi, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787511/ https://www.ncbi.nlm.nih.gov/pubmed/33450669 http://dx.doi.org/10.1016/j.virol.2020.12.020 |
Ejemplares similares
-
Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
por: Takeshita, Masaru, et al.
Publicado: (2022) -
Humoral immunity for durable control of SARS-CoV-2 and its variants
por: Kotaki, Ryutaro, et al.
Publicado: (2023) -
Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-19
por: Uwamino, Yoshifumi, et al.
Publicado: (2021) -
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents
por: Takeshita, Masaru, et al.
Publicado: (2023) -
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models
por: Takeshita, Masaru, et al.
Publicado: (2022)